Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD.

Sohyeon Kim Hung Youl Seok

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)

Our study demonstrated a favorable safety profile with no serious adverse events associated with COVID-19 vaccines in patients with MS, NMOSD, and MOGAD.

Keyphrases

coronavirus disease
sars cov
mass spectrometry
multiple sclerosis
ms ms
respiratory syndrome coronavirus